GloboScience Inc

WHO WE ARE Rapidly evolving scientific advancements and increasing regulatory uncertainty represent a complex environment in which to develop and commercialize new therapeutics. To assist you in addressing these challenges, GloboScience has assembled an exceptional team of international experts in regulatory science, pharmacology, toxicology, clinical development, pharmacovigilance, medical affairs, manufacturing and biostatistics. WHAT WE DO Whether you have a product in nonclinical or clinical development, GloboScience implements an experience-based approach to provide strategic, scientific and regulatory services that results in first cycle approvals and regulatory successes for our clients globally. Our approach allows us to focus and streamline our clients...

Rare diseases and orphan products,biotechnology,regulatory strategy,regulatory science,product development,biologics,biosimilars and generics,oncology,vaccines,labeling,advertising & promotions,nonclinical,clinical development,quality management,gene therapy,cell therapy,biologics license application (bla),marketing authorization applications (maa),new drug applications (nda),investigational new drug (ind) applications,and immunotherapy

Globoscience inc operates in the Biotechnology industry.

Globoscience inc's revenue is 11m - 100m

Globoscience inc has 11 - 50 employees.